drugset / Trial / NCT06351995

Neostigmine and Glycopyrrolate by Iontophoresis

NCT06351995

Phase 3 Active not recruiting 6 enrolled James J. Peters Veterans Affairs Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To determine a lower effective dose of neostigmine to induce bowel evacuation by transcutaneous administration by iontophoresis.

Timeline

Start
2020-11-06
Primary completion
2022-10-25
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrrolate Small molecule 0.014 mg/kg Intravenous
Subject Neostigmine Other / unclassified 0.07 mg/kg Intravenous